| Autor: |
Menezes Pizzichini, Marcia Margaret, de Carvalho-Pinto, Regina Maria, Delfini Cançado, José Eduardo, Rubin, Adalberto Sperb, Neto, Alcindo Cerci, Cardoso, Alexandre Pinto, Cruz, Alvaro Augusto, Godoy Fernandes, Ana Luisa, Blanco, Daniella Cavalet, Vianna, Elcio Oliveira, Junior, Gediel Cordeiro, Rizzo, José Angelo, Fritscher, Leandro Genehr, Ballini Caetano, Lilian Serrasqueiro, Ferreira Pereira, Luiz Fernando, Rabahi, Marcelo Fouad, de Oliveira, Maria Alenita, Lima, Marina Andrade, de Almeida, Marina Buarque, Stelmach, Rafael |
| Zdroj: |
Brazilian Journal of Pulmonology / Jornal Brasileiro de Pneumologia; jan/feb2020, Vol. 46 Issue 1, p1-16, 16p, 3 Diagrams, 2 Charts |
| Abstrakt: |
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the disease, as well as to minimize the risks (of exacerbations, disease instability, accelerated loss of lung function, and adverse treatment effects). That requires an approach that is personalized in terms of the pharmacological treatment, patient education, written action plan, training in correct inhaler use, and review of the inhaler technique at each office visit. A panel of 22 pulmonologists was invited to perform a critical review of recent evidence of pharmacological treatment of asthma and to prepare this set of recommendations, a treatment guide tailored to use in Brazil. The topics or questions related to the most significant changes in concepts, and consequently in the management of asthma in clinical practice, were chosen by a panel of experts. To formulate these recommendations, we asked each expert to perform a critical review of a topic or to respond to a question, on the basis of evidence in the literature. In a second phase, three experts discussed and structured all texts submitted by the others. That was followed by a third phase, in which all of the experts reviewed and discussed each recommendation. These recommendations, which are intended for physicians involved in the treatment of asthma, apply to asthma patients of all ages. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
